Prostate / Prostate Cancer News From Medical News Today
Tue, 16 Mar 2010 13:24:24 +0100
Genentech Provides Update On Phase III Study Of Avastin In Men With Late Stage Prostate Cancer
Genentech, Inc., a wholly owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today the topline results of a Phase III trial led by the U.S...
Sun, 14 Mar 2010 00:00:00 PDT
Researchers Develop Tool To Help Study Prostate Cancer
Van Andel Research Institute (VARI) researchers have developed a new method to better study the cells that line and protect the prostate in relation to the development of cancer. Using the model, they found that normal cells and cancer cells depend on different factors to survive, which could aid in discovering how to target cancer cells without affecting normal cells when developing treatments...
Sat, 13 Mar 2010 01:00:00 PDT
New Way To Get Physical In The Fight Against Cancer
Conventional biological wisdom holds that living cells interact with their environment through an elaborate network of chemical signals. As a result many therapies for the treatment of cancer and other diseases in which cell behavior goes awry focus on drugs that block or disrupt harmful chemical signals...
Sat, 13 Mar 2010 00:00:00 PDT
Abbott Seeks FDA Approval Of A New Six-Month 45-mg Formulation Of Lupron(R) Depot For The Palliative Treatment Of Advanced Prostate Cancer
The U.S. Food and Drug Administration (FDA) has accepted for review the supplemental new drug application (sNDA) of a new six-month 45-mg formulation of Lupron® Depot (leuprolide acetate for depot suspension) for use in the palliative treatment of advanced prostate cancer. Palliative treatment helps to relieve symptoms associated with advanced prostate cancer...
Fri, 12 Mar 2010 03:00:00 PDT
PSA Test Reduces Prostate Cancer Deaths By 40%
When it comes to the documented 40 percent effectiveness of PSA testing in preventing death from prostate cancer, neither the American Cancer Society nor the discoverer of the PSA protein, Richard Ablin, are telling the public the complete story...
Fri, 12 Mar 2010 03:00:00 PDT
Can Multimedia Lead To More Informed Decisions On Prostate Cancer Treatment?
Mount Sinai School of Medicine is leading a study of patients newly-diagnosed with prostate cancer to determine if providing them with multimedia materials can help them make more informed treatment decisions. Michael Diefenbach, Ph.D...
Fri, 12 Mar 2010 01:00:00 PDT
Identifying Patient-Relevant Outcomes In Metastatic Prostate Cancer
While subjective patient-reported outcomes, such as scores from health-status questionnaires, have become an integral part of clinical trials, there is also a need to identify what specific outcomes are the most important ones to target in a given disease context...
Thu, 11 Mar 2010 04:00:00 PDT
AdMeTech Hails New Research That Shows Promise Of MRI To Discriminate Aggressive Prostate Cancer From Dormant Disease
New preliminary data from a pilot study in the Netherlands indicates that imaging tools may help address the most challenging clinical dilemma of prostate cancer care as identified by the hearing of the House Oversight and Government Reform Committee and its expert witnesses last week: to treat or not treat, AdMeTech Foundation's President and CEO Dr. Faina Shtern said today...
Thu, 11 Mar 2010 03:00:00 PDT
First Inherited Prostate Cancer Genetic Mutation Found In African-American Men
Shahriar Koochekpour, MD, PhD, Assistant Professor of Microbiology and Immunology, Biochemistry and Molecular Biology, and Genetics at LSU Health Sciences Center New Orleans, led research that has discovered, for the first time, a genetic mutation in African-American men with a family history of prostate cancer who are at increased risk for the disease. Dr...
Thu, 11 Mar 2010 00:00:00 PDT
Reovirus May Be A Novel Approach To Prostate Cancer Treatment
Researchers in Canada have detected a novel oncolytic viral therapy against prostate cancer with use of a virus called the reovirus, according to study results published in Cancer Research, a journal of the American Association for Cancer Research...
Wed, 10 Mar 2010 03:00:00 PDT
|
